ACC
ABBV icon

Acorn Creek Capital’s AbbVie ABBV Stock Holding History

Acorn Creek Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$507K Sell
2,331
-20
-0.9% -$4.44K 0.18% 35
2025
Q4 		$537K Buy
2,351
+13
+0.6% +$2.96K 0.19% 31
2025
Q3 		$541K Buy
2,338
+171
+8% +$34.8K 0.2% 32
2025
Q2 		$402K Sell
2,167
-51
-2% -$9.48K 0.17% 37
2025
Q1 		$465K Sell
2,218
-71
-3% -$13.8K 0.23% 33
2024
Q4 		$407K Sell
2,289
-53
-2% -$9.74K 0.21% 37
2024
Q3 		$463K Buy
2,342
+65
+3% +$12.1K 0.25% 34
2024
Q2 		$391K Sell
2,277
-44
-2% -$7.29K 0.23% 37
2024
Q1 		$423K Buy
2,321
+199
+9% +$34.3K 0.27% 35
2023
Q4 		$329K Buy
+2,122
New +$309K 0.15% 47

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acorn Creek Capital's ABBV Position: Q1 2026 in Review

Acorn Creek Capital reduced its AbbVie (ABBV) stake by 0.85% in Q1 2026, selling an estimated $4.44K and leaving 2,331 shares worth $507K. The position accounts for 0.18% of the portfolio, ranked #35.

Acorn Creek Capital first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $541K in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Acorn Creek Capital held 2,331 shares of AbbVie worth $507K as of Q1 2026.
  • Acorn Creek Capital sold 20 AbbVie shares in Q1 2026, an estimated $4.44K.
  • AbbVie made up 0.18% of Acorn Creek Capital's portfolio in Q1 2026, its #35 holding.
  • Acorn Creek Capital first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Acorn Creek Capital's AbbVie position peaked at $541K in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Acorn Creek Capital's 13F filing for Q1 2026, filed 12 May 2026.